People
Filter News
Found 34,553 articles
-
Nicole Fevrier Davis Opens New MindBody Mastery Studio and Adds Psychic Assessments and Neurofeedback to her List of Unique Fitness Training Services
5/1/2018
Psychic personal trainer Nicole Fevrier Davis is slated to open her new studio at 10 Roberts Lane in Ridgefield CT on May 2nd.
-
As the end looms near for the embattled Theranos and founder Elizabeth Holmes, there has been new movement with the addition of a noted screenwriter for the planned film about the rise and fall of the beleaguered medtech company.
-
Cronos Group Inc. Appoints Lead Director, Engages Investor Relations Agency and Grants Options
5/18/2018
Jim Rudyk appointed as lead director and has entered into an engagement agreement to retain Athena Advisors LLC as its agency of record for investor relations and corporate communications.
-
Apexigen Expands Leadership Team With Appointment Of Frances Rena Bahjat, Ph.D. Vice President, Discovery Research
5/18/2018
Apexigen, is a clinical-stage biopharmaceutical company
-
Basel, Switzerland-based Novartis announced that between the ASCO meeting and the 23rd Annual Congress of the European Hematology Association (EHA) meeting being held June 14 to 17 in Stockholm, Sweden, it will be presenting 84 abstracts.
-
Precera Bioscience Appoints New CEO and Leadership Team
5/17/2018
Precera Bioscience, Inc. ("Precera"), formerly Sano, appointed Pamela Weir as President and Chief Executive Officer effective January 1, 2018. Ms. Weir brings 30 years of pharmaceutical experience across diverse functions of Commercial, R&D, Operations, Business Development and General Management.
-
Quest Diagnostics adds Helen Torley to Board of Directors
5/17/2018
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Helen I. Torley was elected to serve as a director at the company's 2018 Annual Meeting of Stockholders, expanding the Board of Directors to 10 members.
-
Seattle Genetics Appoints Roger D. Dansey, M.D., Chief Medical Officer
5/17/2018
Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the appointment of Roger D. Dansey, M.D., as Chief Medical Officer. Dr. Dansey brings extensive experience in cancer drug development, most recently from Merck Inc. where he was Therapeutic Area Head for Late Stage Oncology, responsible for the ongoing registration efforts for KEYTRUDA® (pembrolizumab) across multiple tumor types.
-
Triumvira Expands Management Team with Chief Medical Officer and VP of Finance
5/17/2018
Innovative immuno-therapy company welcomes proven leaders in pharma and therapeutics
-
Dune Medical Sets the Stage for Growth, Naming Alan Bond Chief Financial Officer
5/17/2018
Dune Medical Devices has appointed Alan Bond as Chief Financial Officer.
-
Mark A. Goldberg, MD Joins Intensity Therapeutics, Inc. Board of Directors
5/17/2018
Intensity Therapeutics, Inc., a privately held biotechnology company developing proprietary cancer immune-based drug products for direct intratumoral injection, today announced that Mark A. Goldberg, MD has been appointed to the Company's Board of Directors effective May 1, 2018.
-
The first Novartis executive has fallen in the wake of the $1.2 million payment to President Donald Trump’s attorney for consulting work.
-
TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
5/16/2018
Welcomes Renowned Thought Leaders Dr. Malcolm Brenner, Dr. Helen Heslop, and Dr. Cliona Rooney
-
Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors
5/16/2018
Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced the appointment of Bryan Giraudo to its Board of Directors. Mr. Giraudo currently serves as Chief Financial Officer of Gossamer Bio and was previously Senior Managing Director at Leerink Partners.
-
Diabetes Industry Veteran Pawel Fludzinski, Ph.D. Named CEO of AmideBio
5/16/2018
AmideBio LLC, announced today that Dr. Pawel Fludzinski has joined the Company as its new Chief Executive Officer.
-
Liquidia Technologies Appoints Jeri Thomas as Senior Vice President, Commercial
5/16/2018
Ms. Thomas will have responsibility for developing and leading Liquidia’s commercial plans, with initial focus on LIQ861, an inhaled dry powder formulation of treprostinil currently being evaluated in a pivotal Phase 3 safety trial for the treatment of pulmonary arterial hypertension.
-
Clinical Innovations Hires Michael Behling as Chief Financial Officer
5/16/2018
Clinical Innovations is one of the world’s leading medical device-makers focused on labor and delivery and neonatal intensive car.
-
Roivant Expands Senior Leadership with Key Hires
5/16/2018
Dr. Sam Azoulay as Chief Medical Officer and Adele Gulfo as Chief of Commercial Development
-
Quentis Therapeutics Announces the Appointment of Jeanne Magram, Ph.D. as Chief Scientific Officer
5/16/2018
Quentis is a biotechnology company pursuing first-in-class endoplasmic reticulum stress response-targeted therapies to address serious diseases such as cancer
-
Sensei Biotherapeutics Appoints John Celebi as President and Chief Executive Officer
5/16/2018
Experienced Biotechnology Executive to Lead Company’s Growth Strategy for Cancer Immunotherapies, Including Lead Clinical Candidate SNS-301